113 related articles for article (PubMed ID: 18991738)
1. Disturbance of apolipoprotein B100 containing lipoprotein metabolism in severe hyperlipidemic and lipodystrophic HIV patients on combined antiretroviral therapy: evidences of insulin resistance effect.
Ouguerram K; Zair Y; Billon S; Chétiveaux M; Brunet-François C; Ngohou-Bach K; Allavena C; Reliquet V; Milpied B; Magot T; Raffi F; Krempf M
Med Chem; 2008 Nov; 4(6):544-50. PubMed ID: 18991738
[TBL] [Abstract][Full Text] [Related]
2. Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjects.
Ooi EM; Janus ED; Grant SJ; Sinclair LM; R Barrett PH
J Lipid Res; 2010 Aug; 51(8):2413-21. PubMed ID: 20413671
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.
Chan DC; Watts GF; Redgrave TG; Mori TA; Barrett PH
Metabolism; 2002 Aug; 51(8):1041-6. PubMed ID: 12145779
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin decreases de novo cholesterol synthesis and LDL Apo B-100 production rates in combined-hyperlipidemic males.
Cuchel M; Schaefer EJ; Millar JS; Jones PJ; Dolnikowski GG; Vergani C; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1910-7. PubMed ID: 9351353
[TBL] [Abstract][Full Text] [Related]
6. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
Ouguerram K; Magot T; Zaïr Y; Marchini JS; Charbonnel B; Laouenan H; Krempf M
J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
[TBL] [Abstract][Full Text] [Related]
7. Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study.
Petit JM; Duong M; Florentin E; Duvillard L; Chavanet P; Brun JM; Portier H; Gambert P; Verges B
J Lipid Res; 2003 Sep; 44(9):1692-7. PubMed ID: 12869587
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia.
Shahmanesh M; Das S; Stolinski M; Shojaee-Moradie F; Jackson NC; Jefferson W; Cramb R; Nightingale P; Umpleby AM
J Clin Endocrinol Metab; 2005 Feb; 90(2):755-60. PubMed ID: 15522931
[TBL] [Abstract][Full Text] [Related]
9. A study of the metabolism of apolipoprotein B100 in relation to insulin resistance in African American males.
Sumner AE; Falkner B; Diffenderfer MR; Barrett PH; Marsh JB
Proc Soc Exp Biol Med; 1999 Sep; 221(4):352-60. PubMed ID: 10460697
[TBL] [Abstract][Full Text] [Related]
10. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
Millar JS; Brousseau ME; Diffenderfer MR; Barrett PH; Welty FK; Faruqi A; Wolfe ML; Nartsupha C; Digenio AG; Mancuso JP; Dolnikowski GG; Schaefer EJ; Rader DJ
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
[TBL] [Abstract][Full Text] [Related]
11. Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.
Chan DC; Watts GF; Barrett PH; Beilin LJ; Redgrave TG; Mori TA
Diabetes; 2002 Aug; 51(8):2377-86. PubMed ID: 12145148
[TBL] [Abstract][Full Text] [Related]
12. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.
Pont F; Duvillard L; Florentin E; Gambert P; Vergès B
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1726-32. PubMed ID: 12377756
[TBL] [Abstract][Full Text] [Related]
13. Changes in apolipoprotein B100-containing lipoprotein metabolism due to an estrogen plus progestin oral contraceptive: a stable isotope kinetic study.
Duvillard L; Dautin G; Florentin E; Petit JM; Gambert P; Vergès B
J Clin Endocrinol Metab; 2010 May; 95(5):2140-6. PubMed ID: 20200333
[TBL] [Abstract][Full Text] [Related]
14. Normal metabolism of apolipoprotein B100-containing lipoproteins despite qualitative abnormalities in type 1 diabetic men.
Duvillard L; Florentin E; Lalanne-Mistrich ML; Petit JM; Baillot-Rudoni S; Brun-Pacaud A; Brun JM; Gambert P; Vergès B
Diabetologia; 2005 Jul; 48(7):1366-72. PubMed ID: 15918022
[TBL] [Abstract][Full Text] [Related]
15. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
[TBL] [Abstract][Full Text] [Related]
16. In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100.
Das S; Shahmanesh M; Stolinski M; Shojaee-Moradie F; Jefferson W; Jackson NC; Cobbold M; Nightingale P; Umpleby AM
Diabetologia; 2006 Mar; 49(3):538-42. PubMed ID: 16432707
[TBL] [Abstract][Full Text] [Related]
17. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
[TBL] [Abstract][Full Text] [Related]
18. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
Taskinen MR; Packard CJ; Shepherd J
Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
[TBL] [Abstract][Full Text] [Related]
19. Endothelial markers and HIV infection in the era of highly active antiretroviral treatment.
de Larrañaga GF; Bocassi AR; Puga LM; Alonso BS; Benetucci JA
Thromb Res; 2003 May; 110(2-3):93-8. PubMed ID: 12893023
[TBL] [Abstract][Full Text] [Related]
20. The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance: kinetic study using stable isotopes.
Briand F; Bailhache E; Andre A; Magot T; Krempf M; Nguyen P; Ouguerram K
Metabolism; 2008 Jul; 57(7):966-72. PubMed ID: 18555839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
